作者
Ali Hosseinzadeh, Sajad Sahab-Negah, Sairan Nili, Roqayeh Aliyari, Shahrbanoo Goli, Mohammad Fereidouni, Ali Alami, Mohsen Shati, Elham Ahmadnezhad, Shiva Mehravaran, Mansooreh Fateh, Hamidreza Khajeha, Zahra Emamian, Elahe Behmanesh, Sepideh Mahdavi, Mostafa Enayatrad, Alireza Ansari-Moghaddam, Abtin Heidarzadeh, Fariba Shahraki-Sanavi, Seyed Mohammad Hashemi Shahri, Mahlagha Dehghan, Mohammadreza Amini Moridani, Hossein Sheibani, Maryam Abbaszadeh, Reza Jafari, Maryam Valikhani, Ehsan Binesh, Hamid Vahedi, Reza Chaman, Rozita Khodashahi, Mahnaz Amini, Farahzad Jabbari Azad, Fariborz Rezaeitalab, Saeid Amel Jamehdar, Ali Eshraghi, Hamid Sharifi, Seyed Mehdi Hashemi Bajgani, Amin Mahdavi, Abdollah Jafarzadeh, Mehrdad Farokhnia, Saeedeh Ebrahimi, Abbas Pardakhti, Ebrahim Ghaderi, Hasan Soltani, Sedigh Jadidoleslami, Anoush Arianejad, Hamed Gavili, Borhan Moradveisi, Dina Motamedi, Hamed Zare, Toba Kazemi, Mohammad Hassan Emamian
发表日期
2022/8/8
期刊
Bulletin of the World Health Organization
卷号
100
期号
8
页码范围
474
出版商
World Health Organization
简介
Objective
To investigate the incidence of coronavirus disease 2019 (COVID-19) cases, hospitalizations and deaths in Iranians vaccinated with either AZD1222 Vaxzevria, CovIran® vaccine, SARS-CoV-2 Vaccine (Vero Cell), Inactivated (lnCoV) or Sputnik V.
Methods
We enrolled individuals 18 years or older receiving their first COVID-19 vaccine dose between April 2021 and January 2022 in seven Iranian cities. Participants completed weekly follow-up surveys for 17 weeks (25 weeks for AZD1222) to report their COVID-19 status and hospitalization. We used Cox regression models to assess risk factors for contracting COVID-19, hospitalization and death.
学术搜索中的文章
A Hosseinzadeh, S Sahab-Negah, S Nili, R Aliyari… - Bulletin of the World Health Organization, 2022